Surgical Treatment Comparison for Recurrent Lumbar Disc Herniation

NCT ID: NCT00444405

Last Updated: 2020-02-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Study Classification

OBSERVATIONAL

Study Start Date

2007-03-31

Study Completion Date

2009-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to compare patients who underwent decompression/discectomy with pedicle screw fusion to patients who received decompression/discectomy without fusion.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Lumbar disc herniations are quite common and typically improve after surgical correction. However, some patients develop recurrent herniations at the same level. Controversy exists as to why reherniated discs occur. Moreover, existing research does not settle the issue of whether a second decompression/discectomy or a repeat decompression/discectomy with pedicle screw fusion is the more successful treatment. This study is designed to compare differences in patient-reported pain, physical function, and satisfaction between the two types of surgery patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Low Back Pain Recurrent Lumbar Disc Herniation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Recurrent lumbar disc herniation by MRI or CT with history of decompression at the same level in the past
* Recurrent symptomatic history (with or without back pain) with radicular leg pain that improved following the first surgery
* Male or female 18-75 years old
* Flexion and extension x-rays that demonstrate an absence of sponylolisthesis or spondylolisthesis with less than 3 mm of movement

* Documented severe osteoporosis or osteopenia
* Symptoms of low back pain only
* Diabetes mellitus
* Patients with suspected or diagnosed psychological/psychiatric problems that could compromise the reliability of their results
* Lumbar spondylolisthesis on flexion/extension x-rays \> 3 mm
* History of lumbar spine fractures (new or old)
* Any concurrent medical condition that may interfere with the interpretation of efficacy and safety data during the study
* Autoimmune diseases
* Age less than 18 or greater than 75 years

Exclusion Criteria

* Recurrence of disc herniation within 3 months of first decompression
* Multiple level herniated discs
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mercy Research

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Michelle McFarland, MPH, CHRC

Manager - Mercy Research

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Alan M. Scarrow, MD, JD

Role: PRINCIPAL_INVESTIGATOR

St. John's Health System, Missouri

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SJCNS-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.